Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000820413 | SCV000961124 | pathogenic | Tuberous sclerosis 2 | 2021-02-05 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TSC2 protein function. This variant has been observed in several individuals with clinical features of tuberous sclerosis complex (PMID: 17304050, 21309039, Inviate). This variant is also known as L1555P. ClinVar contains an entry for this variant (Variation ID: 50095). This variant is not present in population databases (ExAC no frequency). This sequence change replaces leucine with proline at codon 1578 of the TSC2 protein (p.Leu1578Pro). The leucine residue is highly conserved and there is a moderate physicochemical difference between leucine and proline. |
Tuberous sclerosis database |
RCV000043361 | SCV000067167 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation |